Article
Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner.
Atherosclerosis - 1 Aug 2018
Amersfoort J, Schaftenaar F H, Douna H, van Santbrink P J, Kröner M J, van Puijvelde G H M, Quax P H A, Kuiper J, Bot I
Abstract excerpt
BACKGROUND AND AIMS: Lipocalin-2 (Lcn2) is a glycoprotein which can be secreted by immune cells. Several studies in humans have suggested Lcn2 can be used as a biomarker for the detection of unstable atherosclerotic lesions, partly as it is known to interact with MMP-9. METHODS: In this study, we generated Ldlr-/-Lcn2-/- mice to assess the functional role of Lcn2 in different stages of atherosclerosis....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
